Spinning out
Imperial pilots new route for academic spinouts
Imperial has launched an innovative programme to help academics create research-led businesses.
Stories tagged with 'Imperial Innovations'
App expansion
Imperial-launched Yoyo Wallet app attracts £12 million investment
An innovative cashless payment app pioneered at Imperial has attracted investment of GBP 12 million aiding its expansion into European and US markets.
Face Soft Wins
Face Soft wins Programm/able competition
Face Soft, a computer programme capable of creating 3D reconstructions of faces from 2D images, came in first in the Programm/able finals.
Incubating success
Imperial gives start-ups space to grow
The Duke of York opened Imperial's new technology incubator yesterday, providing a new home for early-stage science and technology companies.
1
Art of Research
Embryo picture claims top spot in scientific images competition
An image of an alligator embryo has won the Art of Research scientific images competition at Imperial.
funding innovation
Pharmaceuticals and universities provide £40m fund for translational research
The Apollo Therapeutics Fund offers Imperial academics and partners a new opportunity to drive forward therapeutic innovation.
Wise women
Imperial chemist receives WISE award for eco-plastics start-up
Professor Charlotte Williams has won an award for women in science, technology, engineering and maths, for founding and leading the start-up Econic.
Innovation culture
Imperial Incubator celebrates billion dollar spinout success
The Imperial Incubator celebrated its spinout companies' extraordinary growth at a special 'graduation' event yesterday.
Award winning idea
Imperial entrepreneurs come out top at the Palace
A device which helps people harness their body's response to rhythm has led an Imperial team to success at a competition hosted by the Duke of York.
potential therapy
New cancer drug to begin trials in multiple myeloma patients
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
5
